SCHEMBL19794368

SCHEMBL19794368

CC1(C)CCC(C)(C)c2cc(-c3cc(-c4ccccc4Br)cc(-c4ccccc4Br)c3)c(Br)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.41
ALDH1A1 P00352 1/20 0.41
RARB P10826 11/20 0.40
RXRA P19793 10/20 0.40
RARG P13631 6/20 0.40
RARA P10276 9/20 0.35
RXRB P28702 5/20 0.34
RXRG P48443 5/20 0.34
TP53 P04637 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015371 1.00 MAPK1 (0.41) MAPK1ALDH1A1RARBRXRARARG
SCHEMBL21662224 0.92 HSD11B1 (0.38) MAPK1ALDH1A1RARBRXRARARG
SCHEMBL27328115 0.85 RARB (0.47) MAPK1ALDH1A1RARBRXRARARG
SCHEMBL24807991 0.82 RARB (0.58) MAPK1ALDH1A1RARBRXRARARG
SCHEMBL25129965 0.78 RXRA (0.45) RARBRXRARARGRARARXRB
SCHEMBL29608697 0.78 RXRA (0.45) RARBRXRARARGRARARXRB
SCHEMBL24809304 0.77 RXRA (0.38) MAPK1RARBRXRARARGRARA
SCHEMBL18015524 0.77 RXRA (0.32) RXRA
SCHEMBL21662016 0.76 HSD11B1 (0.33) RARBRXRARARG
SCHEMBL24809301 0.75 RXRA (0.40) RARBRXRARARGRARARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC MAPK1 4689/4885ALDH1A1 2742/4885RARB 2999/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 MAPK1 4164/4885ALDH1A1 2597/4885RARB 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.